30 Jun MED-TECH INNOVATION | NEWS: Trans-endocardial delivery: The importance of the right solution
Peter Altman, CEO of BioCardia, and Matthieu de Kalbermatten, CEO of CellProthera, comment on trans-endocardial intramyocardial delivery systems for biotherapeutics to treat heart failure, ischemia, and infarction, and the importance of the right delivery solution.
By Peter ALTMAN, Matthieu de KALBERMATTEN | June 23, 2023